[Clinical study of an antispasmodic with a predominantly musculotropic action: 2-piperidinoethyl alpha-phenyl-alpha-piperidinoacetate dihydrochloride (dipiproverine hydrochloride)].
D035843:Biomedical Research; D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central / Q000628:therapy*; D010276:Parasympatholytics
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics
MUSCLE RELAXANTS/therapy